Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale.
For inquiries please contact:
mm@cellbricks.com
Company Details
- Employees
- 28
- Founded
- -
- Address
- Müllerstrasse 178, C/o Campus Of Bayer Ag,germany
- Industry
- Biotechnology
- Website
- cellbricks.com
- Keywords
- 3D Bioprinting, Bioink, Biotechnology, Tissue engineering, Breast cancer, Regenerative medicine, LabModels, Recombinant Collagen, TechBio, Oncology, Pharma, Lifesciences, HealthTech, Biologics, Implants, Autologous Tissue Implants, Breast Reconstruction, Stereolithography, Human Tissue, tissue therapeutics.
- HQ
- Berlin
Cellbricks Therapeutics Questions
Cellbricks Therapeutics's website is cellbricks.com
Cellbricks Therapeutics's LinkedIn profile is https://de.linkedin.com/company/cellbricks
Cellbricks Therapeutics has
28 employees.
View email and phone details for 28
employees at Cellbricks Therapeutics.
Cellbricks Therapeutics's industry is
Biotechnology
Cellbricks Therapeutics's top competitors are
Netri,
4dcell,
Bi/ond,
Cn Bio,
Alveolix,
Hub Organoids,
Tissuse Gmbh,
Emulate, Inc.,
Insphero,
Mimetas.
Cellbricks Therapeutics's categories are Biotechnology
Cellbricks Therapeutics's founding year is 2016
